42 results on '"Väätäinen S"'
Search Results
2. P2 Faster Access to Innovative Therapies with Risk-Sharing Agreements - Cancer Medication Reimbursement Decisions from January 2012 to November 2021 in Finland
3. HPR50 Life-YEARS Gained with Conditional Reimbursement Access to Innovative Oncological and Hematological Medicines in Finland
4. Mapping Forest in Europe by Combining Earth Observation Data and Forest Statistics
5. Variation of Absorption Ångström Exponent in Aerosols From Different Emission Sources
6. Black carbon emissions from flaring in Russia in the period 2012-2017
7. PDG11 Rebate, Discount, or Cost Saving - What Do These Mean for the Economic Risk Sharing Agreements? Case of Finnish Conditional Reimbursement System
8. PDB48 COST AND CAPACITY EFFECTS OF HEALTHYWEIGHTHUB @ VIRTUAL HOSPITAL 2.0 IN FINLAND
9. PDB40 PREDICTIVE ANALYSIS OF COST AND CAPACITY EFFECTS OF THE DIGITALIZED SECONDARY CARE SERVICES FOR INSULIN-DEPENDENT DIABETES PATIENTS @ VIRTUAL HOSPITAL 2.0
10. PIH18 PREDICTED COST AND CAPACITY BENEFITS OF THE DIGITALIZED SECONDARY CARE PATH FOR WOMEN WITH ENDOMETRIOSIS @ VIRTUAL HOSPITAL 2.0
11. Mapping Forest in Europe by Combining Earth Observation Data and Forest Statistics
12. PHP7 - DIGITALIZATION AND CUSTOMER-RESPONSIVE SECONDARY CARE SERVICES POTENTIALLY FREE HEALTH CARE CAPACITY: PREDICTED MONETARY BENEFITS OF VIRTUAL HOSPITAL 2.0
13. Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting
14. Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland
15. Disutility Associated With Erectile Dysfunction in the Middle-Aged Or Older Males
16. PND29 - Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting
17. Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study
18. Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study
19. P-072 Self-rated and caregiver-rated quality of life in Alzheimer's disease: 5-year prospective ALSOVA cohort study
20. PIH60 - Disutility Associated With Erectile Dysfunction in the Middle-Aged Or Older Males
21. PND50 - Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study
22. PND5 - Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study
23. PSY65 - Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland
24. Investigation of absorption Ångström exponents for different emission sources
25. PND5 Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study
26. PND50 Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study
27. PIH60 Disutility Associated With Erectile Dysfunction in the Middle-Aged Or Older Males
28. PSY65 Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland
29. Price tag of glaucoma care is minor compared with the total direct and indirect costs of glaucoma: Results from nationwide survey and register data.
30. Photochemical Aging Induces Changes in the Effective Densities, Morphologies, and Optical Properties of Combustion Aerosol Particles.
31. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
32. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.
33. Low vision status and declining vision decrease Health-Related Quality of Life: Results from a nationwide 11-year follow-up study.
34. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
35. Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany.
36. Impact of Alzheimer's disease on the family caregiver's long-term quality of life: results from an ALSOVA follow-up study.
37. Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC).
38. Self-Rated and Caregiver-Rated Quality of Life in Alzheimer Disease with a Focus on Evolving Patient Ability to Respond to Questionnaires: 5-Year Prospective ALSOVA Cohort Study.
39. Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study.
40. The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.
41. Quality of life along the diabetes continuum: a cross-sectional view of health-related quality of life and general health status in middle-aged and older Finns.
42. The health-related quality-of-life impact of nocturnal awakenings in the middle-aged and older Finnish population.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.